InvestorsHub Logo
Followers 0
Posts 350
Boards Moderated 0
Alias Born 05/29/2013

Re: tmf1955 post# 14474

Friday, 10/18/2013 2:47:31 PM

Friday, October 18, 2013 2:47:31 PM

Post# of 30990
I would argue that the studies for pharmaceuticals have much larger scales.

Most supplements also have a much longer history of studies than Anatabine has.

As far as safety issues... there really isn't enough scale to make any conclusive determinations. 20K users is nothing. And the FDA requirements for tracking side effects are different for supplements vs drugs. There may have been some isolated side effects that simply aren't known to the public or STSI.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.